Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bohai Pharmaceuticals Group is a China-based pharmaceutical company specialized in the development, manufacturing, and commercialization of modernized Traditional Chinese Medicine (TCM) and herbal-based pharmaceuticals. The company's product portfolio targets a range of chronic conditions, with a strong focus on rheumatology, respiratory health, and gastroenterology. Its flagship products include the Tongbi Capsule for rheumatoid arthritis and the Lung Purifying and Cough Relieving Capsule for chronic bronchitis. Operating primarily through its subsidiary, Yantai Bohai Pharmaceuticals Group, the company utilizes GMP-certified manufacturing facilities in Shandong Province. While formerly listed on the US OTC markets, Bohai remains an operational entity focused on the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bohai Pharmaceuticals Group.